BioCentury
ARTICLE | Company News

Metabolex, Shaman deal

January 31, 2000 8:00 AM UTC

Metabolex acquired materials and certain exclusive licenses related to SHMN's diabetes drug discovery program for use within specific geographic territories and therapeutic applications. The licenses ...